针对多发性骨髓瘤中改善CAR-T细胞控制的量身定制策略

Anna Bielowski1, Teresa Kilian1, Sarah Vera-Cruz1

  • 1Chair for Cellular Immunotherapy, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Frontiers in immunology
|February 16, 2026
PubMed
概括

化学抗原受体 (CAR) T细胞疗法对多发性骨髓瘤具有前景,但需要进行安全控制. 抗体与药物联合体 (ADC) 提供了一种新有效的消除CAR-T细胞的方法,提高了治疗的安全性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K